Investments | Investments Available for Sale Securities Our available for sale securities within our investment portfolio consisted of the following as of the dates indicated: September 30, 2018 (In thousands) Amortized Cost Fair Value Gross Unrealized Gains Gross Unrealized Losses Fixed-maturities available for sale: U.S. government and agency securities $ 75,369 $ 72,645 (1) $ — $ 2,724 State and municipal obligations 140,877 139,986 1,859 2,750 Corporate bonds and notes 2,158,991 2,108,779 4,262 54,474 RMBS 258,152 250,056 (2) 4 8,100 CMBS 536,982 525,858 363 11,487 Other ABS 675,686 673,418 967 3,235 Total securities available for sale $ 3,846,057 $ 3,770,742 (3) $ 7,455 $ 82,770 ______________________ (1) Includes securities with a fair value of $10.5 million serving as collateral for FHLB advances. (2) Includes securities with a fair value of $66.1 million serving as collateral for FHLB advances. (3) Includes $7.0 million of fixed-maturity securities loaned to third-party Borrowers under securities lending agreements, classified as other assets in our condensed consolidated balance sheets, as further described below. December 31, 2017 (In thousands) Amortized Cost Fair Value Gross Unrealized Gains Gross Unrealized Losses Fixed-maturities available for sale: U.S. government and agency securities $ 69,667 $ 69,396 $ 96 $ 367 State and municipal obligations 156,587 161,722 5,834 699 Corporate bonds and notes 1,869,318 1,894,886 33,620 8,052 RMBS 189,455 187,229 636 2,862 CMBS 451,595 453,394 3,409 1,610 Other ABS 672,715 674,548 2,655 822 Foreign government and agency securities 31,417 32,207 823 33 Total fixed-maturities available for sale 3,440,754 3,473,382 (1) 47,073 14,445 Equity securities available for sale (2) 176,349 176,065 (1) 1,705 1,989 Total debt and equity securities available for sale $ 3,617,103 $ 3,649,447 $ 48,778 $ 16,434 ______________________ (1) Includes $14.7 million of fixed maturity securities and $13.2 million of equity securities loaned to third-party Borrowers under securities lending agreements, classified as other assets in our condensed consolidated balance sheets, as further described below. (2) Primarily consists of investments in fixed-income and equity exchange-traded funds and publicly-traded business development company equities. For the nine months ended September 30, 2018 , we did not transfer any securities from the available for sale or trading categories. Gross Unrealized Losses and Fair Value of Available for Sale Securities For securities deemed “available for sale” and that are in an unrealized loss position, the following tables show the gross unrealized losses and fair values, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, as of the dates indicated. Included in the amounts as of September 30, 2018 and December 31, 2017 are loaned securities under securities lending agreements that are classified as other assets in our condensed consolidated balance sheets, as further described below. September 30, 2018 ( $ in thousands ) Description of Securities Less Than 12 Months 12 Months or Greater Total # of securities Fair Value Unrealized Losses # of securities Fair Value Unrealized Losses # of securities Fair Value Unrealized Losses U.S. government and agency securities 9 $ 39,342 $ 1,944 5 $ 11,758 $ 780 14 $ 51,100 $ 2,724 State and municipal obligations 25 76,914 2,166 6 13,172 584 31 90,086 2,750 Corporate bonds and notes 383 1,619,774 43,840 35 157,323 10,634 418 1,777,097 54,474 RMBS 23 169,259 3,271 28 80,158 4,829 51 249,417 8,100 CMBS 78 423,684 10,098 11 26,830 1,389 89 450,514 11,487 Other ABS 118 461,978 3,002 16 24,890 233 134 486,868 3,235 Total 636 $ 2,790,951 $ 64,321 101 $ 314,131 $ 18,449 737 $ 3,105,082 $ 82,770 December 31, 2017 ( $ in thousands ) Description of Securities Less Than 12 Months 12 Months or Greater Total # of securities Fair Value Unrealized Losses # of securities Fair Value Unrealized Losses # of securities Fair Value Unrealized Losses U.S. government and agency securities 6 $ 23,309 $ 129 3 $ 9,799 $ 238 9 $ 33,108 $ 367 State and municipal obligations 21 65,898 699 — — — 21 65,898 699 Corporate bonds and notes 152 672,318 4,601 32 139,105 3,451 184 811,423 8,052 RMBS 8 19,943 204 26 101,812 2,658 34 121,755 2,862 CMBS 35 139,353 1,395 4 3,518 215 39 142,871 1,610 Other ABS 92 260,864 777 7 8,297 45 99 269,161 822 Foreign government and agency securities 5 7,397 33 — — — 5 7,397 33 Equity securities 13 149,785 1,989 — — — 13 149,785 1,989 Total 332 $ 1,338,867 $ 9,827 72 $ 262,531 $ 6,607 404 $ 1,601,398 $ 16,434 Although we held securities in an unrealized loss position as of September 30, 2018 , we did not consider those securities to be other-than-temporarily impaired as of such date. For all investment categories, the unrealized losses of 12 months or greater duration as of September 30, 2018 were generally caused by interest rate or credit spread movements since the purchase date, and as such, we expect to recover the amortized cost basis of these securities. As of September 30, 2018 , we did not have the intent to sell any debt securities in an unrealized loss position, and we determined that it is more likely than not that we will not be required to sell the securities before recovery of their cost basis, which may be at maturity; therefore, we did not consider these investments to be other-than-temporarily impaired at September 30, 2018 . Other-than-temporary Impairment Activity. To the extent we determine that a security is deemed to have had an other-than-temporary impairment, an impairment loss is recognized. During the nine months ended September 30, 2018 , we recorded other-than-temporary impairment losses in earnings of $1.7 million due to our intent to sell certain: (i) corporate bonds and notes and (ii) state and municipal obligations, each with an amortized cost basis greater than their fair value. While we recognized other-than-temporary impairment losses related to our intent to sell securities, there were no credit-related impairment losses recognized in earnings during the nine months ended September 30, 2018 . During the nine months ended September 30, 2017 , we recorded other-than-temporary impairment losses in earnings of $1.0 million , including $0.5 million related to a convertible note of a non-public company issuer included in debt securities and $0.5 million related to a privately-placed equity security, because we concluded that we would not recover the amortized cost basis of these securities due to credit deterioration. There were no other-than-temporary impairment losses recognized in accumulated other comprehensive income (loss) during the nine months ended September 30, 2018 or the year ended December 31, 2017 . Trading Securities The trading securities within our investment portfolio, which are recorded at fair value, consisted of the following as of the dates indicated: (In thousands) September 30, December 31, Trading securities: State and municipal obligations $ 185,494 $ 214,841 Corporate bonds and notes 235,422 307,271 RMBS 22,069 29,520 CMBS 50,971 50,561 Foreign government and agency securities — 4,241 Total $ 493,956 $ 606,434 (1) ______________________ (1) At December 31, 2017, includes a de minimis amount of loaned securities under securities lending agreements that are classified as other assets in our consolidated balance sheets, as further described below. Securities Lending Agreements During the third quarter of 2017, we commenced participation in a securities lending program whereby we loan certain securities in our investment portfolio to Borrowers for short periods of time. These securities lending agreements are collateralized financing arrangements whereby we transfer securities to third parties through an intermediary in exchange for cash or other securities. In all of our securities lending agreements, the securities we transfer to Borrowers (loaned securities) may be transferred or loaned by the Borrowers; however, we maintain effective control over all loaned securities, including: (i) retaining ownership of the securities; (ii) receiving the related investment or other income; and (iii) having the right to request the return of the loaned securities at any time. Although we report such securities at fair value within other assets in our condensed consolidated balance sheets, the detailed information regarding investments provided in this Note includes these securities. Under our securities lending agreements, the Borrower is required to provide to us collateral, consisting of cash or securities, in amounts generally equal to or exceeding (i) 102% of the value of the loaned securities ( 105% in the case of foreign securities) or (ii) another agreed-upon percentage not less than 100% of the market value of the loaned securities. Any cash collateral we receive may be invested in liquid assets. The Borrower generally may return the loaned securities to us at any time, which would require us to return the collateral within the standard settlement period for the loaned securities on the principal exchange or market in which the securities are traded. We manage this liquidity risk associated with cash collateral by maintaining the cash collateral in a short-term money-market fund with daily availability. The credit risk under these programs is reduced by the amounts of collateral received. On a daily basis, the value of the underlying securities that we have loaned to the Borrowers is compared to the value of cash and securities collateral we received from the Borrowers, and additional cash or securities are requested or returned, as applicable. In addition, we are indemnified against counterparty credit risk by the intermediary. Key balances related to our securities lending agreements consisted of the following as of the dates indicated: (In thousands) September 30, December 31, Loaned securities (1) : U.S. government and agency securities $ 90 $ — Corporate bonds and notes 7,427 13,862 Foreign government and agency securities — 867 Equity securities 26,847 13,235 Total loaned securities, at fair value $ 34,364 $ 27,964 Total loaned securities, at amortized cost $ 34,651 $ 27,846 Securities collateral on deposit from Borrowers (2) 3,367 9,342 Reinvested cash collateral, at estimated fair value (3) 31,799 19,357 ______________________ (1) Our securities loaned under securities lending agreements are reported at fair value within other assets in our condensed consolidated balance sheets. All of our securities lending agreements are classified as overnight and revolving. None of the amounts are subject to offsetting. (2) Securities collateral on deposit with us from Borrowers may not be transferred or re-pledged unless the Borrower is in default, and is therefore not reflected in our condensed consolidated financial statements. (3) All cash collateral received has been reinvested in accordance with the securities lending agreements and is included in short-term investments in our condensed consolidated balance sheets. Amounts payable on the return of cash collateral under securities lending agreements are included within other liabilities in our condensed consolidated balance sheets. Net Gains (Losses) on Investments and Other Financial Instruments Net gains (losses) on investments and other financial instruments consisted of: Three Months Ended Nine Months Ended (In thousands) 2018 2017 2018 2017 Net realized gains (losses): Fixed-maturities available for sale (1) $ (4,219 ) $ 137 $ (9,030 ) $ (3,552 ) Equity securities (69 ) 33 571 418 Trading securities (260 ) (223 ) (910 ) (6,266 ) Short-term investments 7 14 — (18 ) Other invested assets 83 — 346 — Other gains (losses) 11 7 46 25 Net realized gains (losses) on investments (4,447 ) (32 ) (8,977 ) (9,393 ) Other-than-temporary impairment losses (900 ) — (1,744 ) (1,000 ) Net unrealized gains (losses) on investment securities (2) 1,405 2,353 (17,132 ) 14,517 Total net gains (losses) on investments (3,942 ) 2,321 (27,853 ) 4,124 Net gains (losses) on other financial instruments (538 ) 159 (2,918 ) 836 Net gains (losses) on investments and other financial instruments $ (4,480 ) $ 2,480 $ (30,771 ) $ 4,960 ______________________ (1) Components of net realized gains (losses) on fixed-maturities available for sale include: Three Months Ended Nine Months Ended (In thousands) 2018 2017 2018 2017 Gross investment gains from sales and redemptions $ 814 $ 419 $ 1,831 $ 5,150 Gross investment losses from sales and redemptions (5,033 ) (282 ) (10,861 ) (8,702 ) (2) These amounts include unrealized gains (losses) on investment securities other than securities available for sale. For the three and nine months ended September 30, 2017 , the unrealized gains (losses) on investments exclude the net change in unrealized gains and losses on equity securities. Prior to the implementation of the update to the standard for the accounting of financial instruments effective January 1, 2018, the unrealized gains (losses) associated with equity securities were classified in accumulated other comprehensive income. Net Unrealized Gains (Losses) on Investment Securities The net changes in unrealized gains (losses) from trading securities and equity securities still held at period end were as follows for the periods indicated: Three Months Ended Nine Months Ended (In thousands) 2018 2017 2018 2017 Net changes in unrealized gains (losses) (1) : Equity securities $ 2,971 $ — $ 2,238 $ — Trading securities (2) (2,622 ) 2,694 (18,506 ) 10,011 Net changes in unrealized gains (losses) on investment securities $ 349 $ 2,694 $ (16,268 ) $ 10,011 ______________________ (1) Related only to securities still held at period end. All amounts shown are included in net gains (losses) on investments and other financial instruments. Prior to the implementation of the update to the standard for the accounting of financial instruments effective January 1, 2018, the unrealized losses associated with equity securities were classified in accumulated other comprehensive income. (2) Includes a de minimis amount of net changes in unrealized gains (losses) related to short-term securities. Contractual Maturities The contractual maturities of fixed-maturity investments available for sale were as follows: September 30, 2018 Available for Sale (In thousands) Amortized Cost Fair Value Due in one year or less (1) $ 51,228 $ 51,101 Due after one year through five years (1) 823,314 809,555 Due after five years through 10 years (1) 1,099,144 1,065,556 Due after 10 years (1) 401,551 395,198 RMBS (2) 258,152 250,056 CMBS (2) 536,982 525,858 Other ABS (2) 675,686 673,418 Total (3) $ 3,846,057 $ 3,770,742 ______________________ (1) Actual maturities may differ as a result of calls before scheduled maturity. (2) RMBS, CMBS and Other ABS are shown separately, as they are not due at a single maturity date. (3) Includes securities loaned under securities lending agreements. Other At September 30, 2018 , Radian had an aggregate amount of $76.6 million of U.S. government and agency securities and RMBS, classified as fixed-maturities available for sale within our investment securities portfolio, serving as collateral for our FHLB advances. There were no FHLB advances outstanding at December 31, 2017 . See Note 12 for additional information. Securities on deposit with various state insurance commissioners amounted to $15.4 million and $11.8 million at September 30, 2018 and December 31, 2017 |